Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02986204 · ClinicalTrials.gov registry record · NA

Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT02986204: Completed NA study, sponsored by University of California, Los Angeles.

NCT02986204 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02986204, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This study will investigate in-office ultrasound localization vs localization in radiology for identification and removal of non palpable etonogestrel (ENG) contraceptive implants and aims to help establish best practices in this domain. Investigators will also create an ultrasound image gallery of palpable and non palpable as well as instructional video for non palpable ENG implant removal.

Primary Outcome

Creating an image gallery in order to locate ENG implant using ultrasound and radiological images

Interventions

  • PROCEDURE removal of ENG implant
  • PROCEDURE continuation of ING implant

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-01
Est. Completion 2020-05
Phase NA

What the finished NCT02986204 record still lists

NCT02986204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which removal of ENG implant is the first listed.

NCT02986204 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02986204 about?

NCT02986204 is a clinical study titled "Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant". This study will investigate in-office ultrasound localization vs localization in radiology for identification and removal of non palpable etonogestrel (ENG) contraceptive implants and aims to help establish best practices in this domain. Investigators will also create an ultrasound image gallery of ...

What is the current status of trial NCT02986204?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-01. Estimated completion is 2020-05.

What interventions are being tested in trial NCT02986204?

The interventions under investigation include: removal of ENG implant (PROCEDURE), continuation of ING implant (PROCEDURE).

Who is sponsoring clinical trial NCT02986204?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02986204's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02986204, the US trial registry maintained by the National Library of Medicine. NCT02986204 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.